ChemBK
  • Home
  • Product Category


5-(Pyrazin-2-yl)isoxazole-3-carboxylic acid

5-(2-Pyrazinyl)isoxazole-3-carboxylic Acid

CAS: 1375064-55-3

Molecular Formula: C8H5N3O3

  1. Home
  2. Product Category
  3. 5-(Pyrazin-2-yl)isoxazole-3-carboxylic acid

5-(Pyrazin-2-yl)isoxazole-3-carboxylic acid - Names and Identifiers

Name 5-(2-Pyrazinyl)isoxazole-3-carboxylic Acid
Synonyms 5-(2-Pyrazinyl)isoxazole-3-carboxylic Acid
5-(Pyrazin-2-yl)isoxazole-3-carboxylic acid
3-Isoxazolecarboxylic acid, 5-(2-pyrazinyl)-
5-(pyrazin-2-yl)-1,2-oxazole-3-carboxylic acid
CAS 1375064-55-3

5-(Pyrazin-2-yl)isoxazole-3-carboxylic acid - Physico-chemical Properties

Molecular FormulaC8H5N3O3
Molar Mass191.14
Density1.473±0.06 g/cm3(Predicted)
Boling Point476.8±45.0 °C(Predicted)
pKa2.96±0.10(Predicted)
5-(Pyrazin-2-yl)isoxazole-3-carboxylic acid
Supplier List
SHANGHAI ACMEC BIOCHEMICAL TECHNOLOGY CO., LTD.
Spot supply
Product Name: 5-(2-Pyrazinyl)isoxazole-3-carboxylic Acid Visit Supplier Webpage Request for quotation
CAS: 1375064-55-3
Tel: +86-400-900-4166
Email: product@acmec-e.com
Mobile: +86-18621343501
QQ: 2881950922 Click to send a QQ message
Wechat: 18621343501
WhatsApp: +86-18621343501
SHANGHAI ACMEC BIOCHEMICAL TECHNOLOGY CO., LTD.
Spot supply
Product Name: 5-(2-Pyrazinyl)isoxazole-3-carboxylic Acid Visit Supplier Webpage Request for quotation
CAS: 1375064-55-3
Tel: +86-400-900-4166
Email: product@acmec-e.com
Mobile: +86-18621343501
QQ: 2881950922 Click to send a QQ message
Wechat: 18621343501
WhatsApp: +86-18621343501
View History
5-(Pyrazin-2-yl)isoxazole-3-carboxylic acid
potassium 5-(9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)tetrazol-1-ide
1H-Cyclopenta[7,8]naphtho[2,3-b]furan-7-carboxylic acid, 10-(acetyloxy)-2,3,7,8-tetrahydro-6-methyl-, methyl ester
2,3,5,6,7,8-HEXAHYDRO-4(1H)-QUINAZOLINONE-2-SPIROCYCLOHEXANE
2322-02-3
1616069-32-9
1-(Acetyl-d3)adamantane
1160262-80-5
Benzoic acid, 2-hydroxy-4-Methoxy-3-(3-Methyl-2-butenyl)-6-(2-phenylethyl)-
148379-83-3
  • Home
  • Product Category

© 2015, 2023 ChemBK.com All Rights Reserved | Build: 20230617001